ONCT - Oncternal Therapeutics GAAP EPS of -$2.83 beats by $0.05 revenue of $0.57M beats by $0.44M May, 09 2024 05:01 PM Oncternal Therapeutics Inc. 2024-05-09 17:01:05 ET More on Oncternal Therapeutics Oncternal Therapeutics, Inc. (ONCT) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Oncternal Therapeutics Historical earnings data for Oncternal Therapeutics Financial information for Oncternal Therapeutics For further details see: Oncternal Therapeutics GAAP EPS of -$2.83 beats by $0.05, revenue of $0.57M beats by $0.44M